High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer

To explore the function of NORAD in bladder cancer (BC), and to verify whether NORAD could be used as a biomarker to determine preoperative presence of progression and lymph node metastasis. To our knowledge, it is the first study investigating NORAD and its implications in BC.

Source: Urologic Oncology: Seminars and Original Investigations - March 28, 2018 Category: Urology & Nephrology Authors: Qiaqia Li, Chao Li, Jinbo Chen, Peihua Liu, Yu Cui, Xinyi Zhou, Huihuang Li, Xiongbing Zu Tags: Original article Source Type: research